Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 1/1999

01-12-1999 | Web Report

Break IT - The Breast Cancer Pathology Information Kit

Author: Lesley Ponton

Published in: Breast Cancer Research | Issue 1/1999

Login to get access

Excerpt

Maintained by the Sustaining Oncological Studies (SOS) server. The site was launched in 1996 and is managed by the National Institute of Cancer Research, Genoa, Italy. …
Literature
1.
Metadata
Title
Break IT - The Breast Cancer Pathology Information Kit
Author
Lesley Ponton
Publication date
01-12-1999
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue 1/1999
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr-1999-1-webreport0003

Other articles of this Issue 1/1999

Breast Cancer Research 1/1999 Go to the issue

Paper Report

ErbB-4 dependent proliferation of ER+ breast cells

Paper Report

Liposome-plasmid complexes encoding angiostatin and endostatin inhibit breast cancer in nude mice

Paper Report

Autologous stem-cell transplantation of hematopoietic cells containing the MDR1 cDNA

Paper Report

Report from 16 year UK breast screening trial

Commentary

Killing the umpire: cooperative defects in mitotic checkpoint and BRCA2 genes on the road to transformation

Paper Report

VEGFR-3 and VEGF-C in angiogenesis
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits